The World Health Organization’s international Global Burden of Disease 2016 study1 noted a decrease in rates of age-standardized neurological disorder death from 1990 to 2015, with a significant increase in disease burden due to aging populations and population growth. Considerable US health care system investments into cardiovascular disease and cancer research have resulted in dramatic increases in overall health and survival while potentially increasing neurological diseases’ relative burden.2,3 We estimate neurological disease mortality rate trends at a population scale from January 1999 to December 2017 while investigating regionalized differences within the US.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Neifert SN, McNeill IT, Rothrock RJ, Caridi JM, Mocco J, Oermann EK. Changing Causes of US Neurological Disease Mortality From 1999 to 2017. JAMA Neurol. 2020;77(9):1175–1177. doi:10.1001/jamaneurol.2020.1878
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: